Last reviewed · How we verify
Beta-blockers
Beta-blockers is a Small molecule drug developed by Boehringer Ingelheim. It is currently FDA-approved. Also known as: Atenolol, Bisoprolol, Carvedilol, Metoprolol succinate.
At a glance
| Generic name | Beta-blockers |
|---|---|
| Also known as | Atenolol, Bisoprolol, Carvedilol, Metoprolol succinate, Metoprolol tartrate |
| Sponsor | Boehringer Ingelheim |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Blood Flow Restricted Resistance Exercises Versus Low Level Laser on Cardiac Functions in Patients With Chronic Heart Failure (NA)
- Tapering Heart Failure Medication in Patients With Heart Failure With Recovered Ejection Fraction; Open Label Prospective Random Trial (NA)
- A Study on Yiyang Huoluo Decoction in the Treatment of Coronary Heart Disease (PHASE1, PHASE2)
- N-of-1 Trial to Promote Beta-Blocker Titration in Heart Failure (NA)
- Mechanistic Clinical Trial Comparing the Pharmacokinetics/Pharmacodynamics of Metoprolol in Heart Failure With Reduced Ejection Fraction Patients With Low vs. High Polygenic Score (PHASE4)
- Venous Congestion And Cognitive Dysfunction After Cardiac Surgery
- De-Adoption of Beta-Blockers in Patients With Stable Ischemic Heart Disease (PHASE4)
- Catheter Ablation Versus Anti-arrhythmic Drugs for Ventricular Tachycardia (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Beta-blockers CI brief — competitive landscape report
- Beta-blockers updates RSS · CI watch RSS
- Boehringer Ingelheim portfolio CI
Frequently asked questions about Beta-blockers
What is Beta-blockers?
Beta-blockers is a Small molecule drug developed by Boehringer Ingelheim.
Who makes Beta-blockers?
Beta-blockers is developed and marketed by Boehringer Ingelheim (see full Boehringer Ingelheim pipeline at /company/boehringer-ingelheim).
Is Beta-blockers also known as anything else?
Beta-blockers is also known as Atenolol, Bisoprolol, Carvedilol, Metoprolol succinate, Metoprolol tartrate.
What development phase is Beta-blockers in?
Beta-blockers is FDA-approved (marketed).
Related
- Manufacturer: Boehringer Ingelheim — full pipeline
- Also known as: Atenolol, Bisoprolol, Carvedilol, Metoprolol succinate, Metoprolol tartrate
- Compare: Beta-blockers vs similar drugs
- Pricing: Beta-blockers cost, discount & access